SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001558370-18-000011
Filing Date
2018-01-03
Accepted
2018-01-03 16:33:53
Documents
4
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A f10-qa.htm 10-Q/A 80753
2 EX-10.2 ex-10d2.htm EX-10.2 241284
3 EX-31.3 ex-31d3.htm EX-31.3 5528
4 EX-31.4 ex-31d4.htm EX-31.4 7245
  Complete submission text file 0001558370-18-000011.txt   335992
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-37350 | Film No.: 18505829
SIC: 3841 Surgical & Medical Instruments & Apparatus